Ron Laethem, Ph.D., is a drug disposition scientist with nearly 30 years of experience in the pharmaceutical and biotechnology areas with expertise carrying out in vitro ADME studies. Before Altis Biosystems, Ron was the Director of ADME Services Operations for BioIVT, responsible for setting up and overseeing the in vitro ADME group focusing on non-GLP drug–drug interaction studies for IND and NDA filings. Before BioIVT, Ron served as Associate Director with QPS, Senior Director of R&D for Triangle Research Labs, LLC, and in roles with BD technologies, HepatoTech, Inc, and GSK. Ron received a Ph.D. in biology from Case Western Reserve University.